National Taiwan University Children Hospital Pediatric Neurology Department
Taipei, Taiwan
Location status: Recruiting
NCT Number: NCT05566392
We enroll pediatric patients who were diagnosed COVID-19 for main observation target. We will perform brain MRI and neuropsychiatric evaluation 4-6 months after COVID-19 diagnosed. We also enroll healthy age- and gender-matched participant for cross-over comparison. We will perform same evaluation process one year later for longitudinal evaluation
Interested in participating?
Request Info6 year–18 year
All sexes
Observational
Taipei, Taiwan
Location status: Recruiting
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Brain MRI including diffusion spectrum image, and functional MRI Interview with questionnaires for neuropsychiatric evaluation Near infrared spectroscopy and resting-state connectivity evaluation
Other names: Neuropsychiatric evaluation, Near infrared spectroscopy
Time frame: 1 years after enrollment for primary evaluation
The neuroimage difference between COVID and healthy group and the correlation with neuropsychiatric evaluation
Contact information is provided by the study sponsor or research team.
National Taiwan University Hospital
Other
Longterm Influence of Pediatric Long COVID Syndrome on the Neuropsychiatric Function, Social Function, Neuroimage, and Gut Microbiota
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06928116
Body Temperature Changes, COVID-19
Omaha, Nebraska, United States
View Trial DetailsNCT06940609
COVID-19, Chronic Disease
Albuquerque, New Mexico, United States
View Trial DetailsNCT07224490
COVID-19, Chronic Disease
Boston, Massachusetts, United States
View Trial DetailsNCT06920628
COVID-19, Chronic Disease
Bethesda, Maryland, United States
View Trial Details